medigraphic.com
ISSN 2007-2783 (Print)
Órgano Oficial del Instituto Científico Pfizer

2019, Number 1

<< Back Next >>

Residente 2019; 14 (1)

Síndromes paraneoplásicos: revisión

Arreola-Valdez SA

Language: Spanish
References: 33
Page: 17-26
PDF size: 277.48 Kb.


ABSTRACT

The incidence of cancer has increased over the years, as well as de the scientific and technological advances to study it. Therefore, a better detection and characterization of paraneoplastic syndromes, clinical manifestations of malignancy caused by the tumor, metastasis or treatment (particularly immunotherapy) has been achieved. In this review, the most representative syndromes of each system are highlighted, specially the small cell lung cancer and gynecological tumors that has been related to the great majority of these syndromes, some examples to emphasize are de Lambert-Eaton syndrome, the autoimmune encephalitis and carcinoid syndrome.


REFERENCES

  1. Amber KT, Valdebran M, Grando SA. Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev. 2018; 17 (10): 1002-1010.

  2. Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ. Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol. 1997; 15 (3): 1272-1282.

  3. López-Riverol O, Camacho-Limas CP, Gerson-Cwilich R. Síndromes paraneoplásicos. Diagnóstico y tratamiento. Rev Hosp Jua Mex. 2016; 83 (1-2): 31-40.

  4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144 (5): 646-674.

  5. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016; 23 (1): 27-47.

  6. Martin-Moutot N, de Haro L, Seagar M. Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome. Rev Neurol (Paris). 2004; 160 (5 Pt 2): S28-S34.

  7. Rosenfeld MR, Dalmau J. Paraneoplastic neurologic syndromes. Neurol Clin. 2018; 36 (3): 675-685.

  8. Ruelle L, Bentea G, Sideris S, El Koulali M, Holbrechts S, Lafitte JJ et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature Part 4: Neurological paraneoplastic syndromes, involving the peripheral nervous system and the neuromuscular junction and muscles. Lung Cancer. 2017; 111: 150-163.

  9. Bentea G, Sculier C, Grigoriu B, Meert AP, Durieux V, Berghmans T et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 3: Neurological paraneoplastic syndromes, involving the central nervous system. Lung Cancer. 2017; 106: 83-92.

  10. Sculier C, Bentea G, Ruelle L, Grigoriu B, Coureau M, Gorham J et al. Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions. Lung Cancer. 2017; 111: 164-175.

  11. Armangue T, Leypoldt F, Málaga I, Raspall-Chaure M, Marti I, Nichter C et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol. 2014; 75 (2): 317-3123.

  12. Pujol JL, Di Mercurio JP, Carlander B. Anti-Hu antibodies: a remarkable immulogical phenotype for several paraneoplastic syndromes. Rev Mal Respir. 2013; 30 (7): 521-523.

  13. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004; 56 (5): 715-719.

  14. Saleh, D, Tanner LS. Vohwinkel syndrome. In: Abai B, Abu-Gosh A, Acharya AB, Acharya U, Adigun R, Aeby TC et al, editors. Stat pearls. Treasure Island (FL): StatPearls Publishing; 2018.

  15. Dalmau J, Graus F, Villarejo A, Posner JB, Blumenthal D, Thiessen B et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004; 127 (Pt 8): 1831-1844.

  16. Liao YJ, Safa P, Chen YR, Sobel RA, Boyden ES, Tsien RW. Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo. Proc Natl Acad Sci U S A. 2008; 105 (7): 2705-2710.

  17. Kumar V, Abbas A, Aster J. Robbins & Cotran pathologic basis of disease. 9th edition. Canada: Elsevier Saunders; 2015.

  18. Viau M, Renaud MC, Grégoire J, Sebastianelli A, Plante M. Paraneoplastic syndromes associated with gynecological cancers: A systematic review. Gynecol Oncol. 2017; 146 (3): 661-671.

  19. Wang M, Wang X, Chen T, Zhao J, Peng Y, Chen X et al. Erosive oral lichen planus as a sign of paraneoplastic pemphigus. J Dermatol. 2016; 43 (8): 983.

  20. Kallini JR, Sadeghani K, Khachemoune A. Paraneoplastic palmoplantar keratoderma secondary to metastatic uterine adenocarcinoma. Cutis. 2017; 99 (3): E32-E35.

  21. Martín-Jiménez ML, Palacios-García N, Salas-Antón C, Armengod-Grao L, Aller-Pardo J. Feocromocitoma productor de corticotropoina. Endocrinol Nutr. 2013; 60: 418-420.

  22. DiIenno N, Han E, Maitland C, Kansara V. Hypoglycemia in renal cell carcinoma: a rare paraneoplastic syndrome. Urology. 2019; 124: 10-13.

  23. van der Lely AJ, de Herder WW. Carcinoid syndrome: diagnosis and medical management. Arq Bras Endocrinol Metabol. 2005; 49 (5): 850-860.

  24. Liebman HA. Thrombocytopenia in cancer patients. Thromb Res. 2014; 133 Suppl 2: S63-S69.

  25. Chang H, Kuo MC, Shih LY, Dunn P, Wang PN, Wu JH et al. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Eur J Haematol. 2012; 88 (4): 321-328.

  26. Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014; 21 (1): 18-26.

  27. Delgado MD, Cestari JJ, Lestón-Tauret AH, Alemano G. Síndrome de lisis tumoral. Revisión bibliográfica a 90 años de su descripción. Rev Nefrol Dial Traspl. 2018; 38 (2): 148-159.

  28. Instituto Nacional de Cancerología. Datos epidemiológicos del cáncer de pulmón. [Acceso 01 de noviembre de 2018]. Obtenido de: http://cancerdepulmon.com.mx/#datos-epidemiol%C3%B3gicos

  29. Villalobos-Mora C, Mora-Hernández GA. Tumor de Pancoast. Rev Med Cos Cen. 2015; 72 (614): 153-157.

  30. Simonsen M, Miyabe MM, Ouki HT, Galvão ACR, Leite D, Murayama BAR et al. Myasthenia as a paraneoplastic manifestation of ovarian Cancer. Gynecol Oncol Rep. 2018; 25: 35-36.

  31. Zaborowski MP, Spaczynski M, Nowak-Markwitz E, Michalak S. Paraneoplastic neurological syndromes associated with ovarian tumors. J Cancer Res Clin Oncol. 2015; 141 (1): 99-108.

  32. Gomes-Ferreira M, Lapresa-Alcalde V, García-Sánchez MH, Hernández-Hernández L, Doyague-Sánchez MJ. Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report. Medicine (Baltimore). 2018; 97 (31): e11325.

  33. Murphy N, Shen J, Shih A, Liew A, Khalili H, Yaskiv O et al. Paraneoplastic syndrome secondary to treatment emergent neuroendocrine tumor in metastatic castration-resistant prostate cancer: a unique case. Clin Genitourin Cancer. 2019; 17 (1): e56-e60.




2020     |     www.medigraphic.com